![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Novartis Scores Back-to-Back Jury Wins in Bone Cancer Drug Labeling Suits
Novartis Scores Back-to-Back Jury Wins in Bone Cancer Drug Labeling Suits
January 2, 2013
Novartis and Hollingsworth, its national counsel in litigation over the cancer drug Zometa, got a double dose of good news in the past week with federal juries in Kentucky and St. Louis throwing out failure-to-warn claims by plaintiffs who blamed the company for their jaw disease.
The American Lawyer
The American Lawyer
Upcoming Events
-
21Oct